Top 20 Companies in the Global Lactose Intolerance Treatment Market (2025–2035): Spherical Insights Analysis
RELEASE DATE: Apr 2026 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Introduction
The lactose intolerance treatment market expands because lactose intolerance affects many people. The global population contains approximately 65 to 70 per cent of its people who suffer from Lactose Intolerance or lactase deficiency, and 68 per cent of the population experiences lactose malabsorption, which serves as the main reason for their condition. The treatment options have become more necessary because doctors can now identify digestive disorders through advanced testing techniques. People now adopt new eating patterns which include changes to their dairy consumption and methods for maintaining digestive health, which has led to increased demand for treatment options. The need for treatment options has grown because people now better understand health information, and people in developing nations require medical treatment. The need for treatment options has grown because people now better understand health information and people in developing nations require medical treatment. The need for treatment options has grown because people now better understand health information, and people in developing nations require medical treatment. The need for treatment options has grown because people now better understand health information and people in developing nations require medical treatment.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Lactose Intolerance Treatment Market Size & Statistics
- The Market Size for Lactose Intolerance Treatment Was Estimated to be worth USD 34.4 Billion in 2024.
- The Market Size is Going to Expand at a CAGR of 7.6% between 2025 and 2035.
- The Global Lactose Intolerance Treatment Market Size is anticipated to reach USD 76.7 Billion by 2035.
- North America is estimated to dominate the market during the forecast period in the Lactose Intolerance Treatment Market.
- Asia-Pacific is projected to grow the fastest during the forecast period in the Lactose Intolerance Treatment Market.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Global Casting Rolls Market.
Market Segmentation
Global Lactose Intolerance Treatment Market Size, Share By Type (Lactose Intolerance, Secondary Lactose Intolerance, and Congenital Lactose Intolerance), By Treatment (Food Supplements, Enzyme Lactose Supplements, Probiotics), By Form (Powder, Liquid, and Tablets) and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035.
Regional growth and demand
North America is expected to dominate the market during the forecast period in the Lactose intolerance treatment market.
North America held the majority of the market share by revenue for the lactose intolerance Treatment market. The region's growth is driven by increasing awareness of lactose intolerance and a rising demand for lactose-free products. In the United States, around 36 per cent of people experience lactose malabsorption. The market experiences growth because regulatory authorities support food labelling and health claim standards. The different lactose intolerance rates among various demographic groups create a need for new treatment solutions, which include dietary supplements and lactose-free dairy products. Lactase supplements exist in two forms, which are tablets and drops, and they serve as common treatments for people with genetically based lactose intolerance in North American medical settings.
Asia-Pacific is projected to grow the fastest during the forecast period in the lactose intolerance treatment market.
Asia-Pacific is projected to grow the fastest during the forecast period in the lactose intolerance treatment market. The market for lactose-free products shows strong growth because of three factors, which include rising consumer knowledge about lactose intolerance and lactose-free food, enzyme supplement availability, and increasing disposable incomes of customers who now have access to lactose-free products. The estimated prevalence rate for adults in the Asia-Pacific region ranges between 65 per cent and more than 90 per cent. The region experiences a fast-increasing need for treatment solutions, together with dairy substitute products, enzyme supplements and public health education efforts.
Ready to lead the Lactose Intolerance Treatment Market ?
Discover the regional trends and growth factors shaping the industry. We’re here to assist with expert, personalized data.
Call +1 303 800 4326 or Send us a message for a personalized consultation.
Top 10 Trends in the Lactose Intolerance Treatment Market
- Rising prevalence of lactose intolerance globally
- Growing demand for lactose‑free and dairy‑alternative products
- Increased consumer awareness of digestive health
- Expansion of enzyme (lactase) supplementation options
- Development of microbiome‑based and probiotic therapies
- Personalised nutrition and precision dietary management
- Advances in diagnostic technologies for intolerance detection
- Growth of functional foods targeting gut health
- Expansion in emerging markets (Asia‑Pacific, Latin America)
- Strategic partnerships and product innovations by healthcare firms
1.Increasing prevalence of lactose intolerance worldwide
Around 65-70% of the total population worldwide is suffering from lactose intolerance or lactase deficiency, and the prevalence is higher in Asia, Africa, and South America.
2.Development of microbiome‑based and probiotic therapies
Research shows that specific probiotics and gut microbiome modulation can improve lactose digestion and reduce intolerance symptoms. This trend is driving the creation of personalised, biologically targeted therapies beyond traditional enzyme supplements.
3.Increasing demand for lactose-free and dairy alternative products
Lactose-free milk, yoghurt, cheese, and dairy alternative products are in increasing demand, and the market is growing continuously.
4.Increasing awareness of digestive health among consumers
Today, people are more aware of digestive disorders and their effect on their lives. People are now more aware of lactose intolerance and its effect on their lives, and hence, the increasing awareness is leading to the increasing demand for treatment options.
5.Increasing options in enzyme (lactase) supplementation
Lactase is available in the form of tablets and drops, which can be used by people to overcome their lactose intolerance and continue their normal food intake without showing symptoms of intolerance.
Empower your strategic planning
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the anti-venom market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Top 20 Companies Leading the Lactose Intolerance Treatment Market
- Johnson & Johnson Services, Inc.
- Abbott Laboratories Inc.
- Nestle S.A.
- Danone S.A.
- Chr. Hansen Holding A/S
- Novozymes A/S
- Nature’s Way Products, LLC
- NOW Foods
- Amway (Nutrilite)
- Enzymedica, Inc.
- Deerland Probiotics & Enzymes, Inc.
- GlaxoSmithKline plc
- Lifeway Foods, Inc.
- Valio Ltd.
- Arla Foods
- Kerry Group plc
- DSM (Koninklijke DSM N.V.)
- BioGaia AB
- Nature’s Bounty Co.
- Ganeden Biotech (Kerry Group)
1. Johnson & Johnson
Headquarters: New Brunswick, New Jersey, USA
Johnson & Johnson is a U.S. healthcare giant founded in 1886, with $88.8 billion in revenue in 2024. The company operates worldwide to provide pharmaceuticals, medical devices and consumer health products through its Lactaid brand and its digestive health products, which include enzyme supplements and clinical solutions for lactose intolerance. The company maintains a strong international presence because it operates R&D centres and production facilities and employs thousands across its locations in the Americas, Europe and Asia.
2. Abbott Laboratories
Headquarters: Abbott Park, Illinois, USA
Abbott Laboratories is an American company that established its operations in 1888 and currently maintains its headquarters in Illinois. Abbott generates $8.05 billion in operating income from its extensive product line, which encompasses nutritional items, diagnostic tools and medical devices. The company markets its nutritional brands Similac and other digestive health nutritional products to help people with lactose intolerance control their symptoms and develop better dietary plans in various markets around the world.
3. Nestle S.A.
Headquarters: Vevey, Switzerland
Nestle is a Swiss multinational company that established its operations in 1866 and reported USD 100 billion in revenue during the 2024/25 fiscal year. The company operates as one of the largest food manufacturers worldwide by providing dairy products, nutritional solutions, infant formula, and health science products to more than 185 countries. Nestle offers lactose-free dairy products, nutritional solutions and functional food items that help people with lactose intolerance manage their digestive issues through its various brands.
4. Danone S.A.
Headquarters: Paris, France
The establishment of Danone occurred in 1966, although the company traces its beginnings back to 1919. The company generated 30 billion USD in revenue during the year 2023 because it operates as a worldwide leader in dairy products and plant-based food items. The company provides lactose-free products together with gut health foods, which include Activia and Alpro, to lactose-intolerant customers throughout Europe, the Americas and Asia.
5. Chr. Hansen
Headquarters: Horsholm, Denmark
This company, which operates under the name Chr. Hansen, became part of Novonesis after it merged with Novozymes in the year 2024. The company established its operations in Denmark in 1874, and it recorded $ 1.32 billion in revenue for the year 2022. The company maintains its position as the top producer of cultures and enzymes, together with probiotics, which find use in food fermentation, dairy processing and dietary supplements. Chr. Hansen’s products and its international R&D facilities located in Denmark, the U.S., France and Germany provide essential support for advanced lactose intolerance treatments.
Are you ready to discover more about the Lactose Intolerance Treatment Market?
The report provides an in-depth analysis of the leading companies operating in the Global Lactose Intolerance Treatment Market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardised format that includes:
Company Profile
- Johnson & Johnson
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- Abbott Laboratories Inc.
- Nestle S.A.
- Danone S.A.
- Chr. Hansen Holding A/S
- Novozymes A/S
- Nature’s Way Products, LLC
- NOW Foods
- Amway (Nutrilite)
- Enzymedica, Inc.
- Deerland Probiotics & Enzymes, Inc.
- GlaxoSmithKline plc
- Lifeway Foods, Inc.
- Valio Ltd.
- Arla Foods
- Kerry Group plc
- DSM (Koninklijke DSM N.V.)
- BioGaia AB
- Nature’s Bounty Co.
- Ganeden Biotech (Kerry Group)
Conclusion
The Global Lactose Intolerance Treatment Market size is expected to grow at a compound annual growth rate (CAGR) of 7.6%, from USD 34.4 billion in 2024 to USD 76.7 billion by 2035. Global market expansion is fuelled by rising awareness and diagnosis, a surge in demand for lactose-free diets, and technological advancements in enzyme and microbiome-based treatments. North America is expected to dominate the market during the forecast period due to increasing awareness of lactose intolerance and a rising demand for lactose-free products. Asia-Pacific is projected to grow the fastest during the forecast period due to rising consumer knowledge about lactose intolerance and lactose-free food, enzyme supplement availability, and increasing disposable incomes of customers who now have access to lactose-free products.
Our Report
https://www.sphericalinsights.com/reports/italy-seed-treatment-market
https://www.sphericalinsights.com/reports/italy-compound-feed-market
https://www.sphericalinsights.com/reports/italy-data-center-market
https://www.sphericalinsights.com/reports/italy-food-colorants-market
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI. Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?